Evotec
Xavier Meniche is a prominent Senior Research Scientist and Team Leader in proteomics at Evotec since February 2021, bringing extensive experience in the field. Prior to this role, Xavier served as a Research Scientist in proteomics at BIOASTER from March 2015 to February 2021, and held postdoctoral research positions at UMass Medical School and Université Paris-Sud from 2011 to 2014 and 2008 to 2010, respectively. The academic foundation includes a Doctor of Philosophy degree in Biochimie et biologie moléculaire from Université Paul Sabatier Toulouse III, complemented by a Master’s and Bachelor’s degree in the same field from the same institution, completed between 1999 and 2007.
This person is not in any teams
This person is not in any offices
Evotec
5 followers
Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.